Testing HH-006 treatment for chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This study tests a new drug called HH-006 to see if it can help treat chronic hepatitis B infection. Participants will be grouped by their infection level, and the study checks whether the drug is safe and works to reduce the hepatitis B virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–45 years old and weigh at least 50 kg (men) or 45 kg (women), with a healthy BMI between 18–28
- You have had hepatitis B for at least 6 months, confirmed by blood tests or liver biopsy
- Your blood tests show specific hepatitis B levels that match one of three study groups
- You have not taken certain hepatitis B medications recently (timing varies by group)
- You do not have serious liver damage, cirrhosis, liver cancer, or other major organ diseases
- You are not pregnant, breastfeeding, or co-infected with hepatitis C, HIV, or syphilis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called IB-001 to see how well it works and how safe it is. It is for healthy volunteers and people with chronic hepatitis B. The goal is to find the best dose and understand side effects.
This study tests a new antibody treatment (VIR-3434) for chronic hepatitis B. It aims to see if the antibody can help your immune system control the virus, potentially allowing you to stop your current antiviral medication later.
This study tests a new medicine called AHB-137 for people with chronic hepatitis B who are HBeAg negative and currently on antiviral therapy. The goal is to see if it can help control the virus better or allow you to stop your current medication safely.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
This trial tests a new investigational drug called AHB-171 for people with chronic hepatitis B who are already stable on standard antiviral therapy. It aims to see if the drug is safe and may help control the virus better.
Hear when a new Chronic Hepatitis B Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.